EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Immunomodulation of microglia/macrophages and neutrophils as immunotherapeutic targets in ischemic stroke: A narrative review

Evren Ekingen, Rasit Dinc

Brain Circulation · 2026-07 · 12 (3) · 215-225

DOI: 10.4103/bc.bc_41_25 ↗
AbstractBibliografische Angaben

Abstract

Abstract: Ischemic stroke (IS) remains a critical global issue characterized by high mortality and morbidity rates, primarily caused by neuronal death and brain dysfunction resulting from vascular occlusion. In secondary injuries following IS, inflammation plays a vital role, leading to increased neuronal damage and a poorer prognosis in the early stages. However, inflammation serves a dual purpose in stroke pathophysiology, promoting tissue repair and healing, especially in the later stages of stroke. Mechanical thrombectomy and intravenous thrombolysis are the primary therapeutic choices for IS. However, their narrow therapeutic windows and increased bleeding risks remain problematic. Recent research highlights the therapeutic potential of regulating immune cells, focusing on microglia, macrophages, and neutrophils, due to their dual roles in IS. Current preclinical and clinical studies have shown that this strategy holds promise in the prevention and management of IS. The aim of this review to assess the evolving landscape of immune modulation as therapeutic avenue in ischemic stroke.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →